USPTO serial 99666674
ACEPEP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SIME, JONATHAN PAUL
- Law office
- TMO LAW OFFICE 138
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ACEPEP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
EAST WINDSOR, NJ, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary supplemental drinks in the nature of vitamin and mineral beverages; Pharmaceutical products for the prevention and treatment of cancer; Sports cream for relief of pain; Dietary pet supplements in the form of pet treats; Dietary supplements for controlling cholesterol; Dietary food supplements; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Medicated cosmetics; Pharmaceutical preparations for the treatment of hyperlipidemia; Biological preparations for the treatment of cancer; Food supplements, namely, anti-oxidants; Liquid herbal supplements; Pharmaceutical products for treating respiratory diseases; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Natural biomaterials for augmentation of bone and tissue for medical purposes; Gummy vitamins; Powdered nutritional supplement concentrate; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Mineral supplements; Herbal supplements; Vitamins; Cardiovascular treatment preparations; Vitamin and mineral supplements; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Vitamin and mineral formed and packaged as bars; Multi-vitamin preparations; Mixed vitamin preparations; Medicines for the treatment of gastrointestinal diseases; Medicinal herbs in dried or preserved form; Vitamin tablets; Food supplements; Pharmaceutical preparations acting on the central nervous system; Nutritional supplements, namely, carbohydrates in powdered form; Cholesterol reducers; Herbal drinks used to aid in sleep and relaxation; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Weight management supplements; Health food supplements; Nutritional supplement for eliminating toxins from the body; Pharmaceutical preparation for the treatment of gout; Nutritionally fortified beverages for medical purposes; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Calcium fortified candy for medical purposes; Anti-inflammatory and antipyretic preparations; Medicated eye washes; Natural dietary supplements; Antidiabetic preparations; Dietary supplements for humans and animals; Ketone-based meal replacement bars for weight loss purposes; Ketone ester beverages for use as a dietary supplement; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the prevention of osteoporosis; Dietary and nutritional supplements for atherosclerosis; Dietary and nutritional supplements for Alzheimer's disease; Dietary and nutritional supplements for gout; Dietary supplements; Dietary supplements for pets; Dietary supplements for animals; Dietary supplements for human beings; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Medicinal plant and herb extracts sold as an integral component of medicated cosmetics; Dietary supplements with a cosmetic effect | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 8, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 24, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 22, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 24, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 24, 2026 | NWAP | NEW APPLICATION ENTERED | — |